Skeith K J, Ramos-Remus C, Russell A S
Division of Rheumatology, University of Alberta, Edmonton, Canada.
J Rheumatol. 1994 Mar;21(3):473-5.
To compare the efficacy and toxicity of the newer antifolate 10-ethyl-10-deazaaminopterin (10-EDAM) with methotrexate (MTX) in an animal model of inflammatory arthritis.
Groups of 8 or 9 female Lewis rats received intraperitoneal (ip) Mycobacterium butyricum to induce arthritis, and then one of the antifolates at either 1.0 mg/kg/day by oral gavage or 0.2 mg/kg/2 days ip until 25 days post-induction. Treatment groups were compared with control arthritic and non-arthritic animals. Efficacy was assessed by changes in weight, paw volume, and paw diameter, as well as maximum arthritis index, plasma albumin and plasma iron levels. Toxicity was documented for all groups.
10-EDAM was as effective as MTX at identical doses in preventing arthritis. 10-EDAM produced less toxicity than MTX at the higher dose used but similar toxicity at the lower dose.
10-EDAM may provide an alternative antifolate therapy in the clinical management of inflammatory arthritis, and appears to be less toxic than MTX.
